Richard C.E. Morgan, Chairman

Mr. Morgan is Chief Executive Officer of Amphion Innovations plc (LSE: AMP).

Over the course of his career, Mr. Morgan has been directly involved in the start-up and development of more than 35 companies in the information technology, healthcare, and biotechnology industries. Mr. Morgan was a founder and Chief Executive Officer of Amphion Capital Partners LLC (the predecessor company). He was also the Managing General Partner of Amphion Partners LLC (formerly known as Wolfensohn Partners, LP) a position which he retains, although the partnership is no longer active.

Before joining Wolfensohn, Mr. Morgan spent 15 years with Schroders plc, a British merchant bank, where he was a member of the Board of the merchant bank and head of the Schroder Strategy Group, which he founded. Mr. Morgan, a British citizen, was raised in Kenya and educated in England. He graduated with a B. Engineering First Class Honors from the University of Auckland, New Zealand. In 1982 he completed the Advanced Management Program at the Harvard Business School.

---

 

Robert J. Bertoldi

Mr. Bertoldi is President and Chief Financial Officer of Amphion Innovations plc (LSE: AMP).

Prior to his involvement with the Amphion Innovations, Mr. Bertoldi was a founder, President, and Chief Financial Officer of Amphion Capital Partners LLC (the predecessor company) and VennWorks LLC. Mr. Bertoldi is also a General Partner of Amphion Partners LLC (formerly known as Wolfensohn Partners, LP). Prior to that, he served as Chief Financial Officer for James D. Wolfensohn, Inc. and Hambro America Inc.

He began his career at KPMG and left as a manager in the investment services department. Mr. Bertoldi received a B.A. in Accounting and Economics from Queens College, New York in 1976 and became a Certified Public Accountant in 1978. He is a member of the AICPA and NYSCPA.

---

 

John A. Caruso

Mr. Caruso is Chief Executive Officer of DataTern, Inc. and a Managing Director of Amphion Innovations US, Inc.

He brings over 25 years of experience in IP, start-up activities, and general and FDA counsel and business roles. Mr. Caruso was an associate with the Fish and Neave patent law firm, a patent attorney with Bristol-Myers Squibb and Baxter International, and General Counsel of Enzon Pharmaceuticals and Reckitt Benckiser Pharmaceuticals. Additionally, he has had business roles of Vice President Regulatory Affairs and Business Development in the pharmaceutical industry.

Mr. Caruso has served as a consultant to and board member of biotech, start-up companies. Mr. Caruso is a graduate of Ohio State University with a BSc. in Physiology, and of Cleveland State University Law School.